Ginkgo Bioworks Holdings, Inc. updated revenue guidance for the full year 2024. Due to the changes in the company?s deal structure and focus on cost savings, the company now expects total revenue of $170 million to $190 million in 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.654 USD | -0.38% | -17.68% | -60.76% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.76% | 1.45B | |
+69.84% | 62.86B | |
-0.99% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.36% | 26.46B | |
-21.81% | 18.9B | |
+4.35% | 12.67B | |
+23.98% | 12.27B | |
+28.96% | 12.07B |
- Stock Market
- Equities
- DNA Stock
- News Ginkgo Bioworks Holdings, Inc.
- Ginkgo Bioworks Holdings, Inc. Updates Revenue Guidance for the Full Year 2024